Picture of Orthex Oyj logo

ORTHEX Orthex Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
Basic MaterialsBalancedSmall CapContrarian

Finland's Orthex Q4 net sales fall on reduced year-end pre-loading

Corrects sales number in Key Details table to EUR 22.3 mln from EUR 23 mln

Overview

Nordic houseware firm's Q4 net sales fell 6.6% due to reduced year-end pre-loading

Adjusted EBITA margin improved to 13.6% despite lower sales

Company proposes higher dividend of EUR 0.23 per share

Outlook

Orthex expects global volatility and cost inflation to impact 2026 business environment

Company sees resilience in supply chains as a strategic advantage amid uncertainty

Orthex plans growth through consumer campaigns and cost management in 2026

Result Drivers

REDUCED PRE-LOADING - Decrease in Q4 net sales attributed to reduced year-end pre-loading and big deliveries at end of Q3

COST CONTROL - Improved profitability despite lower sales due to tight cost control and stable raw material prices

Company press release: ID:nWkr4jFbPY

Key Details

MetricBeat/MissActualConsensus Estimate
Q4 SalesEUR 22.3 mln
Q4 Adjusted EBITDAEUR 4.30 mln
Q4 Adjusted EBITAEUR 3 mln
Q4 Basic EPSEUR 0.12
Q4 Operating ProfitEUR 3 mln
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell" The average consensus recommendation for the commodity chemicals peer group is "buy" Wall Street's median 12-month price target for Orthex Oyj is €5.60, about 17.6% above its March 4 closing price of €4.76 The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 10 three months ago For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Orthex Oyj

See all news